Capecitabine
By selecting your device, the default minimum transfer time will be set.
Please Log In to transfer IC
Log In
Add to Complex
Primary Application
Imprint
For what
Digestive
Immune and Lymphatic
Reproductive
Source
Allopathy
For whom
People
Capecitabine is a medication used in cancer treatment, particularly for breast, colorectal, and gastrointestinal cancers. It belongs to a class of drugs called antimetabolites. Capecitabine is converted into an active form in the body, which disrupts the growth of cancer cells by interfering with their DNA replication.
Similar ICs
Imprint
Hydroxycarbamide, also known as hydroxyurea, is a drug classified as an antimetabolite, which stops cells from making and repairing DNA. Hydroxycar...
106
26.1 k
Imprint
This compound belongs to the group of benzimidazole carbamates, drugs widely used in human and veterinary medicine against parasitic worms. The mol...
36
2.61 k
Imprint
Doxorubicin is a chemotherapy medication used to treat several types of cancer such as breast cancer, bladder cancer, Kaposi’s sarcoma, lymphoma, a...
Imprint
In its organic form, germanium binds multiple oxygen atoms and delivers them to the cells and tissue. This form enhances the activities of macropha...
149
10.5 k
Imprint
Fisetin (3,3′,4′,7-tetrahydroxyflavone) is a bioflavonoid antioxidant, which can be found in various fruits and vegetables, such as strawberries, a...
5
310
Imprint
Temozolomide is the most widely used chemotherapeutic agent in the treatment of the most common form of brain cancer, called glioblastoma (GBM). Te...
285
34.2 k
Imprint
Butyrate is produced by healthy bacteria in the large intestine via the fermentation of soluble fiber. It is the primary fuel for cells of the larg...
45
17.2 k
Imprint
IP-6, also known as inositol hexaphosphate, is a naturally occurring polyphosphorylated carbohydrate that is found in mammalian cells, various plan...
84
17.3 k
Imprint
Dichloroacetate (DCA) has been used for decades in the treatment of metabolic acidosis because it blocks the production of lactic acid. In the past...
55
8.84 k
Imprint
All Trans Retinoic Acid (ATRA) is FDA approved in the treatment of promyelocytic leukemia. ATRA is a strong differentiating agent. As such, ATRA ha...
Please select language
Select